A helium balloon, carrying a case with various measuring instruments, in Sembrancher, southwest Switzerland, in January 2021. It is part of an experiment to measure the composition of the air above it in order to better understand the phenomena of pollution accumulation in an alpine valley in winter.
Keystone / Laurent Gillieron
Switzerland spent CHF22.9 billion ($25.5 billion) on research and development in 2019. At 3.15% of GDP, this is above the OECD average of 2.38%.
Switzerland is currently ranked sixth in the 38-member OECD (Organisation for Economic Co-operation and Development), the Federal Statistical Office (FSO) saidExternal link on Thursday. It is at a similar level to Germany and Austria, behind Israel (4.94% of GDP), South Korea and Sweden, and well ahead of France (2.19%).
In 2019, research and development received CHF1.8 billion more funding than in the previous FSO survey in 2017. This increase represents 4.3% per year between 2017 and 2019, compared with 1.2% per year between 2015 and 2017.
At the same time, research as a share of GDP rose slightly, from 3.03% to 3.15%.
FSO
At CHF15.5 billion, the private sector accounts for more than two-thirds (68%) of total research and development spending. Higher education institutions make up a large part of the remaining CHF6.6 billion.
Part of the research carried out in Switzerland is also financed by funding from abroad. In 2019, this amounted to CHF1.4 billion, mainly from private companies.
At the same time, Swiss money finances research abroad, amounting to CHF7.6 billion in 2019. A large part of this (CHF6.8 billion) comes from private companies and is mainly destined for companies in the same group. The remainder is contributed by the government to international programmes and projects, such as those of the European Space Agency.
Staff numbers
The number of people working in research in Switzerland has increased along with the money available. In 2019, the number of full-time equivalents was 8.4% higher than in 2017. The proportion of female researchers remained stable at around 36%.
The 133,000 people employed in research and development in Switzerland accounted for just under 86,000 full-time jobs in 2019, 56% of whom are researchers.
More
More
Pandemic reveals Switzerland’s weak spot in securing foreign talent
This content was published on
Switzerland is increasingly being challenged as a business location because of immigration restrictions. Could the pandemic be a turning point?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss parliament calls for deeper EU security cooperation
This content was published on
The House of Representatives has called on the Swiss government to take a more proactive approach to European security policy.
Switzerland has no US-style fentanyl problem, says health minister
This content was published on
There is very little chance of a US-sized fentanyl epidemic in Switzerland, says health minister Elisabeth Baume-Schneider.
This content was published on
Two fish species recently discovered in Switzerland have been called fluvicola and ommata, following an appeal to the public for names.
Convicted ex-shipowner achieves partial success in Swiss court
This content was published on
The Federal Supreme Court orders lower court to reassess part of its verdict against former Swiss shipowner Hans-Jürg Grunder.
This content was published on
A Swiss moratorium on the genetic engineering of plants, which expires at the end of 2025, could be extended for five years.
SWISS airline achieves second-best profit in history
This content was published on
Revenues soared for Swiss International Air Lines in 2024, contributing to the second-largest profit in the company's history.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Are Big Pharma’s big innovation plans what we need?
This content was published on
Our analysis of what the biggest global companies in Switzerland are up to. This week: Big Pharma's R&D plans, coronavirus impact, and #cryptoleaks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.